Evidence map›Paper›PMID 40301656›Full record

ReviewNature biotechnology2025

Enabling next-generation anaerobic cultivation through biotechnology to advance functional microbiome research.

Thomas Clavel, Franziska Faber, Mathieu Groussin, Dirk Haller, Jörg Overmann, Charlie Pauvert, Mathilde Poyet, Joel Selkrig, Bärbel Stecher, Athanasios Typas and 4 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Supplementation with abioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Thomas ClavelFunctional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany. tclavel@ukaachen.de.ORCID http://orcid.org/0000-0002-7229-5595
Franziska FaberInstitute for Hygiene and Microbiology, Faculty of Medicine, University of Würzburg, Würzburg, Germany.
Mathieu GroussinInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Dirk HallerChair of Nutrition and Immunology, School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-6977-4085
Jörg OvermannLeibniz-Institut DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.ORCID http://orcid.org/0000-0003-3909-7201
Charlie PauvertFunctional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany.ORCID http://orcid.org/0000-0001-9832-2507
Mathilde PoyetInstitute of Experimental Medicine, Kiel University, Kiel, Germany.
Joel SelkrigHost-Microbe Interactomics Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany.
Bärbel StecherZIEL - Institute for Food and Health, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-7445-5193
Athanasios TypasEuropean Molecular Biology Laboratory, Molecular Systems Biology Unit, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-0797-9018
Maria J G T VehreschildGoethe University Frankfurt, University Hospital Frankfurt, Department II of Internal Medicine, Infectious Diseases, Frankfurt am Main, Germany.
Alexander J WestermannHelmholtz Institute for RNA-Based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.ORCID http://orcid.org/0000-0003-3236-0169
David WylensekFunctional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany.ORCID http://orcid.org/0000-0002-8424-5712
Lisa MaierInterfaculty Institute for Microbiology and Infection Medicine Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-6473-4762

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 8005512001Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 8005512901Deutsche Forschungsgemeinschaft (German Research Foundation) 395357507Deutsche Forschungsgemeinschaft (German Research Foundation) 403224013Deutsche Forschungsgemeinschaft (German Research Foundation) 445552570Deutsche Forschungsgemeinschaft (German Research Foundation) 492620490Deutsche Forschungsgemeinschaft (German Research Foundation) 6270048 NFDI 5/1Deutsche Forschungsgemeinschaft (German Research Foundation) 6270054 NFDI 28/1Deutsche Forschungsgemeinschaft (German Research Foundation) EXC2124Deutsche Forschungsgemeinschaft (German Research Foundation) MA 8164/1-2Deutsches Zentrum für Infektionsforschung (German Center for Infection Research) 503-5-7-06.709_00EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) EvoGutHealth, 865615EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) GUT-CHECK, 101040214EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) gutMAP, 101076967EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) uCARE, 819454
6 · The paper itself

Abstract

Microbiomes are complex communities of microorganisms that are essential for biochemical processes on Earth and for the health of humans, animals and plants. Many environmental and host-associated microbiomes are dominated by anaerobic microbes, some of which cannot tolerate oxygen. Anaerobic microbial communities have been extensively studied over the last 20 years using molecular techniques, especially next-generation sequencing. However, there is a renewed interest in microbial cultivation because isolates provide the basis for understanding the taxonomic and functional units of biodiversity, elucidating novel biochemical pathways and the mechanisms underlying microbe-microbe and microbe-host interactions and opening new avenues for biotechnological and clinical applications. In this Perspective, we present areas of research and applications that will benefit from advancement in anaerobic microbial cultivation. We highlight key technical and infrastructural hurdles associated with the development and deployment of sophisticated cultivation workflows. Improving the performance of cultivation techniques will set new trends in functional microbiome research in the coming years.

Indexed as

Bacteria, AnaerobicBiotechnologyMicrobiotaAnaerobiosisHigh-Throughput Nucleotide SequencingHumans

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.